SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies (ROLR) is trending due to its binding partnership with crypto.com/us to launch an event-based prediction markets product in the United States. This news is driving immense excitement and high volatility, with the community speculating on the low-float stock's potential to capitalize on a multi-trillion dollar market. Traders are actively discussing the possibility of a substantial short squeeze and comparing ROLR to previous explosive runs within the online gambling and crypto sectors.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as the market anticipates significant developments, fueled by its unique Optical Interposer technology's critical role in next-generation AI data centers and co-packaged optics. Community discussions highlight its potential for high-speed, low-power interconnects, with recent industry shifts toward advanced optics from major players like NVIDIA and Marvell intensifying speculation around future orders and partnerships.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is a hot topic as multiple analysts have recently reiterated or upgraded ratings and raised price targets, emphasizing its AI-powered AXON platform and expanding e-commerce presence. Despite this bullish institutional sentiment, the stock experiences significant intraday volatility, leading to active community discussions about market manipulation and the viability of buying dips or shorting rallies.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity is trending amid a wave of analyst upgrades, citing its strengthening mobile advertising platform and the growth potential of new commerce tools within the broader real-time 3D development space. The community is actively discussing a potential breakout beyond previous resistance levels, with many viewing recent dips as buying opportunities while others remain cautious given historical volatility. Optimism is fueled by the performance of its Vector AI platform and strategic partnerships, indicating confidence in its long-term trajectory across gaming, digital twins, and AI applications.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending due to robust preliminary revenue guidance for its flagship MS drug Briumvi, which is surpassing expectations for 2025 and 2026 and positioning it for potential blockbuster status. The community is actively discussing Briumvi's best-in-class profile and market share expansion, especially amidst a competitor's recent regulatory setback, while also expressing frustration over the stock's current valuation and perceived manipulation.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is generating significant market discussion amid the J.P. Morgan Healthcare Conference, driven by recent advancements in its obesity drug pipeline and the appointment of a Chief Commercial Officer. The community is sharply divided, with many anticipating a major partnership or acquisition given a peer CEO's remarks on substantial M&A spending, while others express skepticism over recent stock performance and the company's presentation style.

New Century Logistics (BVI) Ltd. is a holding company, which is doing business through its subsidiaries, providing air and ocean export and import freight forwarding & logistics services. It offers cargo space, cargo pick up, off-airport air cargo security screening, palletization, preparation of shipping documentation, arrangement of customs clearance to cargo handling at ports and other related services. The company was founded on April 24, 2019 and is headquartered in Hong Kong.

New Century Logistics (BVI) Ltd.

New Century Logistics

New Century Logistics (NCEW) is gaining significant attention following its strategic acquisition announcement in Asia and partnerships for innovative drone-based last-mile delivery. The community is actively discussing its extremely low share float and drawing comparisons to other "Hong Kong low float" stocks that have recently experienced substantial, volatile runs. This focus, coupled with chatter about its high short interest, positions NCEW as a speculative play within the logistics sector.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark (CLSK) is trending due to its notable market momentum, with the community observing its strong performance relative to peers like IREN. A primary talking point among investors revolves around the company's ambitious growth plans and potential share dilution concerns to finance these expansions, despite an overarching bullish sentiment.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is trending due to a convergence of compelling clinical advancements and anticipated corporate catalysts. The community is actively discussing strong pancreatic cancer data, a recent FDA filing for recurrent skin cancer, and awaiting Japanese regulatory approval, all contributing to significant market momentum. Investors are keenly focused on the company's presentation at a major healthcare conference this week, alongside widespread anticipation of increased institutional interest.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is trending amidst robust Black Friday/Cyber Monday sales results, demonstrating strong merchant activity even with earlier platform issues. The community is actively discussing the company's aggressive AI integrations with major platforms, which is fueling bullish sentiment around its long-term growth as a leading e-commerce infrastructure provider, while some continue to debate its current valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$NNOX is there anything to look forward to with this company? Been out of the loop for months so thought I’d ask the twits

StockTwits for iOS

Nano X Imaging Ltd

 is there anything to look forward to with this company? Been out of the loop for months so thought I’d ask the twits

Oracle Corp.

Lilly(Eli) & Co

Micron Technology Inc

Meta Platforms Inc

Vanguard S&P 500 ETF

Alphabet Inc Class A

Senseonics Holdings Inc

Barvy

@iamthewalrus88 Nothing has changed; we are waiting to see the first ARC that generates revenue, in a hospital in Morocco, Nigeria, Ghana, or in US, is the same. For more information, please contact the CEO.

StockTwits For Android 

 Nothing has changed; we are waiting to see the first ARC that generates revenue, in a hospital in Morocco, Nigeria, Ghana, or in US, is the same. For more information, please contact the CEO.

Dante sPeak

a few of my posts on NNOX @iamthewalrus88 https://tickervault.substack.com/p/erez-meltzer-nano-x-imagings-ceo  
https://tickervault.substack.com/p/my-nnox-short-selling-analysis

Substack

Erez Meltzer: Nano-X Imaging's CEO - A Track Record of Turnarounds, Exits, and Conservative Execution

My NNOX short selling analysis

StockTwits Web

NiSun International Enterprise Development Group Co Ltd

Lightspeed Commerce Inc - Ordinary Shares (Sub Voting)

Thierry Cases

@DantesPeak Thanks friend, lol contact the CEO made me giggle.

 Thanks friend, lol contact the CEO made me giggle.

@iamthewalrus88  
1)NNOX needs to revenue. 
2) Revenue is held up by regulatory (FDA). 
3) FDA QSub told them they can&#39;t be equivalent to x-ray, because they are 3D. 
4) NNOX submitted 510k for  2D adapter to their device, so they can get the adjunctive use limitations removed - and people can use the ARC, full body scan, INSTEAD of an x-ray. 
5) Clearance for the 2D adapter is expected within next 4 weeks. 
6) Additional 510k submission will need to come with data (with 2D adapter) that shows equivalency... in order to finally remove adjunctive limitation. 
7) Revenue streams will open up immediately after adjunctive limitations are removed - expecting by July 1st. 
8) Full company profitability expected in 12-18 months.

Enrique Viladomiu

  
1)NNOX needs to revenue. 
2) Revenue is held up by regulatory (FDA). 
3) FDA QSub told them they can't be equivalent to x-ray, because they are 3D. 
4) NNOX submitted 510k for  2D adapter to their device, so they can get the adjunctive use limitations removed - and people can use the ARC, full body scan, INSTEAD of an x-ray. 
5) Clearance for the 2D adapter is expected within next 4 weeks. 
6) Additional 510k submission will need to come with data (with 2D adapter) that shows equivalency... in order to finally remove adjunctive limitation. 
7) Revenue streams will open up immediately after adjunctive limitations are removed - expecting by July 1st. 
8) Full company profitability expected in 12-18 months.